These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 4947785

  • 21. [Regulatory problems in tumor immunology].
    Pasternak G.
    Allerg Immunol (Leipz); 1973; 19(2-4):307-19. PubMed ID: 4281633
    [No Abstract] [Full Text] [Related]

  • 22. [Why does a tumor grow?].
    Dosne Pasqualini C, Laguens RP, Colmerauer ME, Segal A.
    Medicina (B Aires); 1974; 34(6):659-64. PubMed ID: 4617837
    [No Abstract] [Full Text] [Related]

  • 23. [Relationship between immunity and disease course in hemoblastoses].
    Tilz GP.
    Wien Med Wochenschr; 1972 Nov 21; 122(43):646-9. PubMed ID: 4655806
    [No Abstract] [Full Text] [Related]

  • 24. Relationship between blocking and unblocking activity and tumor growth in vivo.
    Sjögren HO, Bansal SC.
    Natl Cancer Inst Monogr; 1972 Dec 21; 35():231-5. PubMed ID: 4349148
    [No Abstract] [Full Text] [Related]

  • 25. Suppressed development of cytotoxic lymphoid cells in tumor-immunized mice.
    Martin WJ, Wunderlich JR, Macdonald J.
    Isr J Med Sci; 1973 Mar 21; 9(3):324-31. PubMed ID: 4710040
    [No Abstract] [Full Text] [Related]

  • 26. Cell mediated immune reactions "in vitro". Reactivity of lymphocytes from animals sensitized to chicken erythrocytes, tuberculin or transplantation antigens.
    Chapuis B, Brunner KT.
    Int Arch Allergy Appl Immunol; 1971 Mar 21; 40(3):321-39. PubMed ID: 5313314
    [No Abstract] [Full Text] [Related]

  • 27. [Tumor immunology].
    Gallmeier WM, Oettgen HF.
    Dtsch Med Wochenschr; 1968 May 31; 93(22):1114-8. PubMed ID: 4297719
    [No Abstract] [Full Text] [Related]

  • 28. Immune stimulation-inhibition of experimental cancer metastasis.
    Fidler IJ.
    Cancer Res; 1974 Mar 31; 34(3):491-8. PubMed ID: 4812256
    [No Abstract] [Full Text] [Related]

  • 29. Immunological enhancement.
    Russell PS.
    Transplant Proc; 1971 Mar 31; 3(1):960-6. PubMed ID: 4941150
    [No Abstract] [Full Text] [Related]

  • 30. Dynamics of immunologic enhancement.
    Kaliss N.
    Transplant Proc; 1970 Mar 31; 2(1):59-67. PubMed ID: 4940355
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Ly 11.2: a cell surface antigen that may identify murine lymphocytes susceptible to transformation by oncogenic agents.
    Meruelo D, Paolino A, Flieger N, Offer M, Dworkin J.
    Fed Proc; 1981 Oct 31; 40(12):2717-20. PubMed ID: 6269904
    [No Abstract] [Full Text] [Related]

  • 34. Suppression of Gross leukemia cell-surface antigens: a kind of antigenic modulation.
    Aoki T, Johnson PA.
    J Natl Cancer Inst; 1972 Jul 31; 49(1):183-92. PubMed ID: 5037434
    [No Abstract] [Full Text] [Related]

  • 35. Is antibody essential for enhancement of skin allograft survival following preinjection of donor lymphocyte antigens?
    Lee CK, Reif AE, Deterling RA.
    Transplantation; 1972 Mar 31; 13(3):339-43. PubMed ID: 4553736
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. In vitro expression of homograft reactions.
    Lawrence HS, al-Askari S.
    Transplant Proc; 1969 Mar 31; 1(1):400-2. PubMed ID: 4944249
    [No Abstract] [Full Text] [Related]

  • 40. Introduction: diagnosis and immunotherapy of cancer.
    Klein E.
    Natl Cancer Inst Monogr; 1972 Dec 31; 35():331-9. PubMed ID: 4349151
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.